QUALY-IPF-PPP
Prospective, Observational Study of the Factors Affecting Patient and Physician Perceptions of Quality of Life in Idiopathic Pulmonary Fibrosis (IPF)
Sponsor study identifier
observational
100
1 country
1
Study Start
September 23, 2019
Actual (reported)Primary Completion
November 27, 2019
Actual (reported)Study Completion
December 1, 2020
Actual (reported)This study aims to evaluate the differences between patient's and their physicians' perception of quality of life and the effect of disease severity and co-morbidities. Patients and physicians will complete two sets of questionnaires at an initial clinic visit and again six months later.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 23, 2019
Actual (reported)October 25, 2019
Actual (reported)November 1, 2019
Actual (reported)November 27, 2019
Actual (reported)December 1, 2020
Actual (reported)Patient and Physician Responses to the Kings Brief ILD (K-BILD) Questionnaire
A comparison of physician and patient reported quality of life based on responses to the Kings Brief ILD Questionnaire (K-BILD). The domain and total score ranges are 0-100 where a score of 100 represents best health status.
6 months
Patient and Physician Responses to the EuroQol five dimensional 5-Level (EQ-5D-5L) questionnaire
A comparison of physician and patient reported quality of life based on responses to the EuroQol five dimensional 5-Level (EQ-5D-5L) questionnaire. The domain ranges are 1-5 and the total score ranges are 5-25 where a score of 5 represents best health status. The visual analog scale portion of the questionnaire ranges from 0 to 100 where a score of 100 represents best health status.
6 months
Patient and Physician Responses to the Raghu Quality of Life in Interstitial Lung Disease (RQ-LIFE-ILD) Questionnaire
A comparison of physician and patient reported quality of life based on responses to a novel visual analog scale questionnaire the Raghu Quality of Life in Interstitial Lung Disease (RQ-LIFE-ILD) Questionnaire. The domain ranges are 0 to 10 and the total score ranges are 0 to 50 where a score of 0 represents best health status.
6 months
All participants in this study will hold a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) as detailed above. As IPF occurs only in adults all subjects must be 18 years of age or older. Both men and women will be recruited for the study. Subjects of all ethnicities and racial minorities will be recruited. Physicians who are seeing these patients for regular clinical visits during the study will also be included.
University of Washington - Center for Interstitial Lung Disease
Seattle, Washington, 98195, United States
Scallan C, Strand L, Hayes J, Kadura S, Collins B, Ho L, Spada C, Canestaro W, Kolb M, Raghu G. R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life. Eur Respir J. 2022 Jan 13;59(1):2100917. doi: 10.1183/13993003.00917-2021. Print 2022 Jan.
Ganesh Raghu, MD
University of Washington
100 participants (actual enrollment reported by the registry).
First Submitted
October 25, 2019
First Posted
November 1, 2019
Study Start
September 23, 2019
Actual (reported)Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis
Contact the study team to confirm eligibility.
Primary Completion
November 27, 2019
Actual (reported)Study Completion
December 1, 2020
Actual (reported)Last Updated
December 11, 2024
Record last verified: 2024-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: